Cargando…

Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases

PURPOSE: To (1) examine the occurrence and concentrations of aPS/PT and aPL in inflammatory bowel disease (IBD) patients at the beginning of and during anti-TNF-alpha therapy with infliximab; (2) investigate the link of the aPS/PT and aPL presence with antibodies to infliximab (ATI) formation; and (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malíčková, Karin, Ďuricová, Dana, Bortlík, Martin, Janatková, Ivana, Zima, Tomáš, Lukáš, Milan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389083/ https://www.ncbi.nlm.nih.gov/pubmed/26000139 http://dx.doi.org/10.1007/s13317-012-0045-0

Ejemplares similares

Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases
por: Malíčková, Karin, et al.
Publicado: (2011)

Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers
por: Malíčková, Karin, et al.
Publicado: (2017)

Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015)

Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?
por: Cerna, Karin, et al.
Publicado: (2023)

ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS
por: Cerna, Karin, et al.
Publicado: (2022)

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study
por: Mitrova, Katarina, et al.
Publicado: (2021)

Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
por: Humlová, Zuzana, et al.
Publicado: (2010)

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
por: Tselios, Konstantinos, et al.
Publicado: (2013)

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
por: Egri, Natalia, et al.
Publicado: (2021)

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
por: Sciascia, Savino, et al.
Publicado: (2019)

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
por: Radin, Massimo, et al.
Publicado: (2020)

Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study
por: Brodska, Helena, et al.
Publicado: (2009)

Low frequency of phosphatidylserine/prothrombin complex antibodies in a cohort of patients with anticardiolipin antibodies and recent thrombosis
por: Locht, H
Publicado: (2003)

Establishment of a rat model of thrombosis induced by intravenous injection of anti-phosphatidylserine–prothrombin complex antibody
por: Yamada, Mai, et al.
Publicado: (2017)

Anti-Phosphatidylserine, Anti-Prothrombin, and Anti-Annexin V Autoantibodies in Antiphospholipid Syndrome: A Real-Life Study
por: Roselli, Daniele, et al.
Publicado: (2023)

The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation
por: Fabris, Martina, et al.
Publicado: (2014)

Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells
por: Hoffmann, Peter R., et al.
Publicado: (2001)

Infliximab in inflammatory bowel disease
por: Papamichael, Konstantinos, et al.
Publicado: (2019)

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
por: Sciascia, Savino, et al.
Publicado: (2021)

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2022)

Biology of phosphatidylserine (PS): basic physiology and implications in immunology, infectious disease, and cancer
por: Calianese, David C., et al.
Publicado: (2020)

Elevation of procalcitonin in chronic dialysed patients
por: Brodska, H, et al.
Publicado: (2008)

Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells
por: Cifù, A., et al.
Publicado: (2019)

Inflammatory bowel disease of the lung: The role of infliximab?()
por: Hayek, Adam J., et al.
Publicado: (2015)

Efficacy of Infliximab Biosimilar for Maintenance Therapy in Pediatric Inflammatory Bowel Disease Following Infliximab Originator
por: Hinshaw, Amie, et al.
Publicado: (2022)

SPS/PS Meeting, pt. A
por: Gabrielse, G, et al.
Publicado: (1997)

A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma
por: Wang, Xue-Ping, et al.
Publicado: (2017)

Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit
por: Silva, Vanessa M., et al.
Publicado: (2020)

Management of inflammatory bowel disease in poor responders to infliximab
por: Guerra, Iván, et al.
Publicado: (2014)

PS, It’s Complicated: The Roles of Phosphatidylserine and Phosphatidylethanolamine in the Pathogenesis of Candida albicans and Other Microbial Pathogens
por: Cassilly, Chelsi D., et al.
Publicado: (2018)

Phosphatidylserine-Gold Nanoparticles (PS-AuNP) Induce Prostate and Breast Cancer Cell Apoptosis
por: Radaic, Allan, et al.
Publicado: (2021)

Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease
por: Hellmann, Jennifer, et al.
Publicado: (2021)

Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies
por: Balendran, Clare A., et al.
Publicado: (2017)

A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene
por: Mansory, Eman M., et al.
Publicado: (2021)

Phosphatidylserine synthase 2 and phosphatidylserine decarboxylase are essential for aminophospholipid synthesis in T rypanosoma brucei
por: Farine, Luce, et al.
Publicado: (2017)

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States
por: Smith, Joshua T, et al.
Publicado: (2021)

Interference of M-protein on prothrombin time test – case report
por: Margetić, Sandra, et al.
Publicado: (2016)

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lnule41m04e0bpt673fflc0ddc